Kolexia
Istvan Marion Santé publique
Istvan Marion
Santé publique
Hôpital Hôtel-Dieu Nantes
Nantes, France
61 Activités
363 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Troubles liés à une substance Surdose Accident vasculaire cérébral Urgences Maladie de Parkinson Crampe musculaire Angiopathies intracrâniennes Complications postopératoires Agranulocytose

Collaborateurs

Voir plus
Vigneau-Victorri Caroline
Vigneau-Victorri Caroline
Hôpital Hôtel-Dieu Nantes, Nantes, France
Laforgue Edouard-Jules
Laforgue Edouard-Jules
Hôpital Hôtel-Dieu Nantes, Nantes, France
Jolliet Pascale
Jolliet Pascale
Hôpital Hôtel-Dieu Nantes, Nantes, France
Guerlais Marylene
Guerlais Marylene
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
Lilly
3 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Nitrous oxide in France: Evolution of complications reported to the French monitoring system in the context of information from health authorities and regulatory measures
The International journal on drug policy   05 octobre 2023
Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data.
Epidemiology and psychiatric sciences   19 septembre 2023
Experience or recommendations? The reasons of psychiatrists to choose an antipsychotic or another in schizophrenia
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Preventing misuse of psychotropic treatment, interest of the WHO 6-step method for rationale prescribing
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
ZORRO project: An innovative method to assess the overall impact in pharmacoepidemiology
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Clinical reality of drug interactions with CBD: ESCAPE study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session.
Current drug metabolism   01 juin 2023
Nitrous oxide: a unique official French addictovigilance national survey.
Frontiers in public health   03 mai 2023
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change.
European journal of public health   04 avril 2023
First results of the French OCTOPUS survey among festival attendees: a latent class analysis.
Harm reduction journal   29 mars 2023